产品详情
文献和实验
相关推荐
Recombinant Protein Production
Antibody Production
Monoclonal Antibody Production
Recombinant Antibody Production
Cell Line Development
Hybridoma Development
Stable Cell Line Development
SARS-CoV-2 Antibodies and Antigens
Additional Services
Antibody Sequencing
Antibody Optimization
Related Services
InVivo BioTech Services GmbH 是一家领先的德国合同制造组织，在哺乳动物细胞培养以及单克隆抗体和重组蛋白的生产方面拥有 20 多年的经验。
总部和主要生产设施位于 Hennigsdorf 的生物技术园区，InVivo 还在柏林市中心经营着一个较小的第二个工厂，历史始于二十多年前。自 1998 年成立以来，该公司一直在不断发展壮大，如今展示了大约 2500 平方米（~26900 平方英尺）的实验室和操作空间。
2017 年，BRUKER Daltonics 与 InVivo 合并，获得了生产体外诊断试剂盒、生物标准品和化学基质的可靠合作伙伴。
我们提供丰富的服务组合
InVivo 通过复杂的生产流程和一整套专有耗材和试剂提供具有成本效益的外包解决方案。
全面的服务组合包括抗体开发、子类转换、小规模到批量生产、抗体测序和偶联。特别关注通过哺乳动物 HEK293 和 CHO 细胞中的瞬时基因表达生产重组抗体和蛋白质。
此外，InVivo 提供杂交瘤和稳定 CHO 细胞系开发、细胞系转移至无血清培养基、低内毒素水平生产和细胞库。其他服务包括冻干、免疫分析开发、DNA 设计和大规模 DNA 制备。这使 InVivo 成为满足您所有研究需求的一站式解决方案。
InVivo BioTech Services GmbH is a leading German contract manufacturing organization with more than 20 years of experience in mammalian cell culture and production of monoclonal antibodies and recombinant proteins.
With the headquarter and main production facility being located on the biotech campus in Hennigsdorf, InVivo also operates a smaller, second facility in the heart of Berlin, where history started more than two decades ago. Since its inception in 1998, the company has consistently grown over time and exhibits today approximately 2 500 square meters (~ 26 900 square feet) of laboratory and operational space.
In 2017 BRUKER Daltonics incorporated InVivo to gain a reliable partner for the production of in vitro diagnostic kits, biological standards and chemical matrices.
WE OFFER A RICH SERVICE PORTFOLIO
InVivo provides cost-effective outsourcing solutions through sophisticated production processes and a whole set of proprietary consumables and reagents.
The comprehensive service portfolio includes antibody development, subclass switches, small- to bulk-scale production, antibody sequencing and conjugation. A special focus lies on the production of recombinant antibodies and proteins via transient gene expression in mammalian HEK293 and CHO cells.
Furthermore, InVivo offers hybridoma and stable CHO cell line development, transfer of cell lines to serum-free media, low endotoxin level production, and cell banking. Further services include lyophilization, immunoassay development, DNA design and large-scale DNA preparation. This makes InVivo a one-stop solution for all your research needs.
Antibody Production
Monoclonal Antibody Production
Recombinant Antibody Production
Cell Line Development
Hybridoma Development
Stable Cell Line Development
SARS-CoV-2 Antibodies and Antigens
Additional Services
Antibody Sequencing
Antibody Optimization
Related Services
InVivo BioTech Services GmbH 是一家领先的德国合同制造组织，在哺乳动物细胞培养以及单克隆抗体和重组蛋白的生产方面拥有 20 多年的经验。
总部和主要生产设施位于 Hennigsdorf 的生物技术园区，InVivo 还在柏林市中心经营着一个较小的第二个工厂，历史始于二十多年前。自 1998 年成立以来，该公司一直在不断发展壮大，如今展示了大约 2500 平方米（~26900 平方英尺）的实验室和操作空间。
2017 年，BRUKER Daltonics 与 InVivo 合并，获得了生产体外诊断试剂盒、生物标准品和化学基质的可靠合作伙伴。
我们提供丰富的服务组合
InVivo 通过复杂的生产流程和一整套专有耗材和试剂提供具有成本效益的外包解决方案。
全面的服务组合包括抗体开发、子类转换、小规模到批量生产、抗体测序和偶联。特别关注通过哺乳动物 HEK293 和 CHO 细胞中的瞬时基因表达生产重组抗体和蛋白质。
此外，InVivo 提供杂交瘤和稳定 CHO 细胞系开发、细胞系转移至无血清培养基、低内毒素水平生产和细胞库。其他服务包括冻干、免疫分析开发、DNA 设计和大规模 DNA 制备。这使 InVivo 成为满足您所有研究需求的一站式解决方案。
InVivo BioTech Services GmbH is a leading German contract manufacturing organization with more than 20 years of experience in mammalian cell culture and production of monoclonal antibodies and recombinant proteins.
With the headquarter and main production facility being located on the biotech campus in Hennigsdorf, InVivo also operates a smaller, second facility in the heart of Berlin, where history started more than two decades ago. Since its inception in 1998, the company has consistently grown over time and exhibits today approximately 2 500 square meters (~ 26 900 square feet) of laboratory and operational space.
In 2017 BRUKER Daltonics incorporated InVivo to gain a reliable partner for the production of in vitro diagnostic kits, biological standards and chemical matrices.
WE OFFER A RICH SERVICE PORTFOLIO
InVivo provides cost-effective outsourcing solutions through sophisticated production processes and a whole set of proprietary consumables and reagents.
The comprehensive service portfolio includes antibody development, subclass switches, small- to bulk-scale production, antibody sequencing and conjugation. A special focus lies on the production of recombinant antibodies and proteins via transient gene expression in mammalian HEK293 and CHO cells.
Furthermore, InVivo offers hybridoma and stable CHO cell line development, transfer of cell lines to serum-free media, low endotoxin level production, and cell banking. Further services include lyophilization, immunoassay development, DNA design and large-scale DNA preparation. This makes InVivo a one-stop solution for all your research needs.
北京美科美生物技术开发有限公司
代理商实名认证
钻石会员
入驻年限：11年
